New Frontiers: Precision Medicine a ‘Unique Signature’ for Pediatric Cancer Patients
Update: 2024-03-08
Description
Precision medicine, also known as personalized medicine, has revolutionized how physicians and scientists treat and study disease. According to Theodore Laetsch, MD, an oncologist at Children’s Hospital of Philadelphia, this ability to track and tailor individual patients’ unique genetic signatures has the most transformative potential in pediatric cancer. In this episode of Bench to Bedside, Dr. Laetsch shares how his new Frontier Program, the Center for Precision Medicine for High-risk Pediatric Cancer, harnesses advanced technologies and a growing multi omics database to optimize outcomes for childhood cancer patients.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
